As of July 4, 2025, Shenzhen Mindray Bio-Medical Electronics Co Ltd (300760.SZ) reports a Net Margin of 31.77%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Shenzhen Mindray Bio-Medical Electronics Co Ltd's Net Margin
Over recent years, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 31.77% |
| 2023-12-31 | 33.16% |
| 2022-12-31 | 31.64% |
| 2021-12-31 | 31.66% |
| 2020-12-31 | 31.67% |
This slight upward trend highlights how Shenzhen Mindray Bio-Medical Electronics Co Ltd manages its overall profitability and cost control over time.
Comparing Shenzhen Mindray Bio-Medical Electronics Co Ltd's Net Margin to Peers
To better understand Shenzhen Mindray Bio-Medical Electronics Co Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co Ltd (300760.SZ) | 31.77% |
| APT Medical Inc (688617.SS) | 32.59% |
| Jafron Biomedical Co Ltd (300529.SZ) | 30.63% |
| Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) | 30.22% |
| Shenzhen Lifotronic Technology Co Ltd (688389.SS) | 30.09% |
| Nanjing Vishee Medical Technology Co Ltd (688580.SS) | 25.49% |
Compared to its competitors, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.